Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Fri Dec 15 17:17:12 GMT 2023
by
admin
on
Fri Dec 15 17:17:12 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | HUMAN |
| Source Materials Parent | |
| Part | BLOOD PLASMA |
| Fraction Material Type | PROTEIN |
| Fraction Name | IGG |
| Record UNII |
129L90A25N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
15386
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
||
|
FDA ORPHAN DRUG |
52190
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
||
|
NDF-RT |
N0000184165
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/06/408
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
||
|
NCI_THESAURUS |
C2701
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
N0000007920
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY | Immunoglobulins [Chemical/Ingredient] | ||
|
C80826
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY | |||
|
DB13886
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY | |||
|
129L90A25N
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY | |||
|
22178
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
ALTERNATIVE | RxNorm | ||
|
N0000184009
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY | Virus Neutralization [MoA] | ||
|
1997443
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY | |||
|
129L90A25N
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY | |||
|
N0000183365
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY | Passively Acquired Immunity [PE] | ||
|
N0000184152
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY | Virus-specific Hyperimmune Globulins [Chemical/Ingredient] | ||
|
SUB128472
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY | |||
|
339086-15-6
Created by
admin on Fri Dec 15 17:17:12 GMT 2023 , Edited by admin on Fri Dec 15 17:17:12 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| TARGETED ANTIGEN | IMMUNOLOGICAL |
|
HUMAN HERPESVIRUS 5 | 7COI029E6K |